Vicky Makker

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 45 papers. Top paper: “Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer”.

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer

British Journal of Cancer(2020)10.1038/s41416-020-01041-x

N/A

2.6DataRank · unranked

90 citations

Michael S. Gordon, Monica Mita, Brian I. Rini, Vicky Makker, Teresa Macarulla +15 more

HER2-Mediated Internalization of Cytotoxic Agents in ERBB2 Amplified or Mutant Lung Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0215

N/A

0.854DataRank · unranked

295 citations

Flavia Michelini, Sandra Misale, Emiliano Cocco, Laura Baldino, Yanyan Cai +44 more

Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses

Nature Medicine(2024)10.1038/s41591-024-02942-7

N/A

0.790DataRank · unranked

26 citations

Beryl Manning‐Geist, Qin Zhou, Tara E. Soumerai, Aliya Holland, Arnaud Da Cruz Paula +23 more

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-007929

N/A

0.783DataRank · unranked

19 citations

Matthew H. Taylor, Carol Aghajanian, Allen Lee Cohn, Marcia S. Brose, Christopher Di Simone +12 more

Extreme Outlier Analysis Identifies Occult Mitogen-Activated Protein Kinase Pathway Mutations in Patients With Low-Grade Serous Ovarian Cancer

Journal of Clinical Oncology(2015)10.1200/jco.2015.62.4726

N/A

0.702DataRank · unranked

107 citations

Brooke E. Sylvester, Helen Won, Gregory McDermott, Deborah DeLair, Ricardo Ramirez +20 more

A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)

Gynecologic Oncology(2024)10.1016/j.ygyno.2023.12.028

N/A

0.583DataRank · unranked

12 citations

M. Herman Chui, Qin Zhou, Alexia Iasonos, Debra Sarasohn, Seth M. Cohen +9 more

Genetic and molecular subtype heterogeneity in newly diagnosed early- and advanced-stage endometrial cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.015

N/A

0.533DataRank · unranked

34 citations

Deborah F. DeLair, Lorenzo Ferrando, Daniel Fix, Robert A. Soslow, Kay J. Park +16 more

Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician’s Choice

European Journal of Cancer(2023)10.1016/j.ejca.2023.03.015

N/A

0.434DataRank · unranked

17 citations

Nicoletta Colombo, Antonio Casado, Alessandro D. Santin, Émeline Colomba, David S. Miller +14 more

A phase II study of MK-2206, an AKT inhibitor, in uterine serous carcinoma

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.100974

N/A

0.416DataRank · unranked

15 citations

Niya Xiong, Andrea P. Myers, Nabihah Tayob, Victoria Engvold, Madeline Polak +14 more

Final analysis of multi-histology basket trial expansion of ado-trastuzumab emtansine in patients with HER2 amplified cancers.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3025

N/A

0.345DataRank · unranked

9 citations

Vicky Makker, Darren J. Buonocore, Ronglai Shen, Rona Yaeger, Michelle S. Ginsberg +15 more

Tyrosine kinase inhibitor toxicities: A society of gynecologic oncology review and recommendations

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.007

N/A

0.312DataRank · unranked

7 citations

Erin K. Crane, June Y. Hou, John Nakayama, Jennifer MacDonald, Kathleen Lutz +3 more

The genomic landscape of distant metastatic endometrial cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.006

N/A

0.292DataRank · unranked

6 citations

Subhiksha Nandakumar, Elizabeth Kertowidjojo, Bastien Nguyen, Lea A. Moukarzel, Arnaud Da Cruz Paula +12 more

Basket study of oral progesterone antagonist onapristone extended release in progesterone receptor-positive recurrent granulosa cell, low-grade serous ovarian cancer, or endometrioid endometrial cancer

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.026

N/A

0.269DataRank · unranked

5 citations

Lindsey Finch, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +14 more

Laparoscopy with or without robotic assistance does not negatively impact long-term oncologic outcomes in patients with uterine serous carcinoma

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.064

N/A

0.241DataRank · unranked

4 citations

Derman Başaran, Christian Dagher, Dib Sassine, Benny Brandt, Kendal Rosalik +7 more

Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2023-004842

N/A

0.165DataRank · unranked

2 citations

Victoria Wan, Michael Finlan, Qin Zhou, Alexia Iasonos, Oliver Zivanovic +14 more

Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer

medRxiv(2024)10.1101/2024.06.07.24308618

N/A

0.104DataRank · unranked

1 citations

Eduardo Ortiz, Caroline S. Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman +10 more

Decreased HER2 expression in endometrial cancer following anti‐HER2 therapy

The Journal of Pathology(2023)10.1002/path.6230

N/A

0DataRank · unranked

11 citations

David N. Brown, Arnaud Da Cruz Paula, Edaise M. da Silva, Amir Momeni Boroujeni, Jorge S. Reis‐Filho +5 more

Isolated vaginal recurrence in women with stage I endometrial cancer

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.10.011

N/A

0DataRank · unranked

4 citations

Han Cun, Olga T. Filippova, Jennifer J. Mueller, Kaled M. Alektiar, Lora H. Ellenson +7 more

Germline drivers of gynecologic carcinosarcomas

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.04.024

N/A

0DataRank · unranked

8 citations

Sushmita Gordhandas, Ozge Ceyhan‐Birsoy, Yelena Kemel, Anna Maio, Erin Salo‐Mullen +22 more

Oncologic outcomes based on lymphovascular space invasion in node-negative FIGO 2009 stage I endometrioid endometrial adenocarcinoma: a multicenter retrospective cohort study

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005746

N/A

0DataRank · unranked

32 citations

Pernille Bjerre Trent, Rofieda Alwaqfi, Ben Davidson, Lora H. Ellenson, Qin Zhou +9 more

Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer

Journal of Clinical Investigation(2024)10.1172/jci180516

N/A

0DataRank · unranked

19 citations

Eduardo Ortiz, Caroline S. Jiang, Christian Dagher, Carlo Sevilla, Jeffrey Girshman +10 more

A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or Recurrent Endometrial Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1999

N/A

0DataRank · unranked

16 citations

Qin Zhou, Alexia Iasonos, William A. Zammarrelli, Britta Weigelt, Lora H. Ellenson +17 more

Prognosis of isolated tumor cells and use of molecular classification in early stage endometrioid endometrial cancer

International Journal of Gynecological Cancer(2024)10.1136/ijgc-2024-005522

N/A

0DataRank · unranked

9 citations

Nadeem R. Abu‐Rustum, Kaled M. Alektiar, Vicky Makker, Ying L. Liu, Dmitriy Zamarin +8 more

Impact of adjuvant therapy on oncologic outcomes in uterine-confined clear cell carcinoma of the endometrium

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.08.019

N/A

0DataRank · unranked

5 citations

Silvana Pedra Nobre, Dib Sassine, Gretchen Glaser, Ane Gerda Zahl Eriksson, Beyhan Ataseven +7 more

Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101651

N/A

0DataRank · unranked

8 citations

Pernille Bjerre Trent, Rofieda Alwaqfi, Ben Davidson, Lora H. Ellenson, Qin Zhou +12 more

Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody–drug conjugate

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.023

N/A

0DataRank · unranked

2 citations

Matthew Flint, M. Herman Chui, Jason Konner, Claire F. Friedman, Angela K. Green +14 more

Prognostic value of “aggressive” histology in surgically staged clinically uterine-confined endometrial carcinoma

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.102656

N/A

0DataRank · unranked

2 citations

Jennifer J. Mueller, Yukio Sonoda, Amir Momeni Boroujeni, Vicky Makker, Roisin E. O’Cearbhaill +4 more

Erratum to ‘Effect of substantial lymphovascular space invasion on location of first disease recurrence in surgical stage I endometrioid endometrial adenocarcinoma’ [International Journal of Gynecological Cancer Volume 35 Issue 4 (2025) 101651]

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2025.101962

N/A

0DataRank · unranked

0 citations

Pernille Bjerre Trent, Rofieda Alwaqfi, Ben Davidson, Lora H. Ellenson, Qin Zhou +12 more

Metabolomic signatures of hypocaloric dietary interventions associate with breast cancer risk in the Nurses’ Health Study II

medRxiv(2025)10.1101/2025.08.18.25333805

N/A

0DataRank · unranked

0 citations

Cheng Peng, Oana A. Zeleznik, William Jones Dartora, Maurice A. Hurd, Alex Buga +10 more

Basket study of oral progesterone antagonist onapristone extended-release in combination with anastrozole in progesterone receptor-positive recurrent adult-type granulosa cell tumor of the ovary

International Journal of Gynecological Cancer(2025)10.1016/j.ijgc.2024.100005

N/A

0DataRank · unranked

3 citations

Sarah Andres, Alexia Iasonos, Qin Zhou, Jeffrey Girshman, Rashmi Chhetri-Long +15 more

A phase I open-label study of selinexor with paclitaxel and carboplatin in patients with advanced ovarian or endometrial cancers

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.10.019

N/A

0DataRank · unranked

16 citations

Rachel N. Grisham, Karen A. Cadoo, Chrisann Kyi, William P. Tew, Claire F. Friedman +14 more

Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas

Modern Pathology(2021)10.1038/s41379-021-00997-2

N/A

0DataRank · unranked

78 citations

Kelly A. Devereaux, Cao Jin, David YunTe Lin, Yanming Zhang, Antonio Marra +5 more

Characterization and Management of Adverse Reactions in Patients with Advanced Endometrial Carcinoma Treated with Lenvatinib Plus Pembrolizumab

The Oncologist(2021)10.1002/onco.13883

N/A

0DataRank · unranked

34 citations

Matthew H. Taylor, Ana Oaknin, Antonio Casado, Robert Orlowski, Lea Dutta +4 more

Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

Annals of Oncology(2022)10.1016/j.annonc.2022.05.009

N/A

0DataRank · unranked

636 citations

Tjalling Bosse, Carien L. Creutzberg, Gonzalo Giornelli, Philipp Harter, Florence Joly +7 more

Endometrial carcinosarcoma

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2022-004073

N/A

0DataRank · unranked

95 citations

Isabelle Ray‐Coquard, Nicole Concin, Natalie Y.L. Ngoi, Philippe Morice, Giuseppe Caruso +35 more

Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry

European Journal of Cancer(2022)10.1016/j.ejca.2022.07.018

N/A

0DataRank · unranked

41 citations

Paul Guedeney, Nicholas Palaskas, Lorenz Lehmann, Stéphane Éderhy, Han Zhu +86 more

Impact of obesity and white adipose tissue inflammation on the omental microenvironment in endometrial cancer

Cancer(2022)10.1002/cncr.34356

N/A

0DataRank · unranked

26 citations

Lorenzo Ferrando, Anthe A. Stylianou, Stephanie Lobaugh, Michelle Wu, Silvana Pedra Nobre +9 more

Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.028

N/A

0DataRank · unranked

23 citations

Eric Rios Doria, Jason Konner, Stuart M. Lichtman, Qin Zhou, Alexia Iasonos +18 more

Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.012

N/A

0DataRank · unranked

22 citations

Sherry Shen, Bradley J. Monk, David S.P. Tan, Angélica Nogueira‐Rodrigues, Daisuke Aoki +3 more

Integration of clinical sequencing and immunohistochemistry for the molecular classification of endometrial carcinoma

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.05.059

N/A

0DataRank · unranked

89 citations

Amir Momeni Boroujeni, Claire F. Friedman, Pier Selenica, Qin Zhou, Michelle Wu +16 more

Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2022.7254

N/A

0DataRank · unranked

63 citations

William A. Zammarrelli, Eric Rios‐Doria, Angela K. Green, Vicky Makker, Sushmita Gordhandas

HER2 Genetic Intratumor Heterogeneity Is Associated With Resistance to Trastuzumab and Trastuzumab Emtansine Therapy in Recurrent High-Grade Endometrial Cancer

Modern Pathology(2023)10.1016/j.modpat.2023.100299

N/A

0DataRank · unranked

21 citations

Weining Ma, David N. Brown, Arnaud Da Cruz Paula, Qin Zhou, Alexia Iaosonos +11 more

Adverse events and oncologic outcomes with combination lenvatinib and pembrolizumab for the treatment of recurrent endometrial cancer

Gynecologic Oncology(2023)10.1016/j.ygyno.2023.09.010

N/A

0DataRank · unranked

19 citations

Weining Ma, Kevin Espino, Sushmita Gordhandas, Effi Yeoshoua, Sarah Ehmann +8 more

Comprehensive analysis of germline drivers in endometrial cancer

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad016

N/A

0DataRank · unranked

21 citations

Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings, Anna Maio, Yelena Kemel +37 more

Pathogenic germline variants in patients with endometrial cancer of diverse ancestry

Cancer(2023)10.1002/cncr.35071

N/A

0DataRank · unranked

14 citations

Sushmita Gordhandas, Kanika Arora, Eric Rios‐Doria, Karen A. Cadoo, Amanda Catchings +26 more